PT  - JOURNAL ARTICLE
AU  - Abdul Badran
AU  - Carla Moran
AU  - Alasdair J Coles
TI  - Hypothyroid ataxia complicating monoclonal antibody therapy
AID  - 10.1136/practneurol-2017-001713
DP  - 2017 Dec 01
TA  - Practical Neurology
PG  - 482--484
VI  - 17
IP  - 6
4099  - http://pn.bmj.com/content/17/6/482.short
4100  - http://pn.bmj.com/content/17/6/482.full
SO  - Pract Neurol2017 Dec 01; 17
AB  - We present a case of cerebellar dysfunction due to severe hypothyroidism induced by pembrolizumab, a member of the ‘immune checkpoint inhibitor’ class of cancer immunotherapies. Thyroxine replacement completely resolved his symptoms and signs. We also discuss the neurological immune-related complications of checkpoint inhibitors.